Lane Labs BeneFin Is Unapproved Drug - FDA Complaint
This article was originally published in The Tan Sheet
Executive Summary
FDA is seeking a permanent injunction against the sale of Lane Labs-USA's BeneFin, SkinAnswer and MGN-3 products, alleging they are "unapproved drugs" and "illegally promoted as treatments for cancer and other diseases."
You may also be interested in...
Lane Labs To Pay Consumer Restitution Under Permanent Injunction
The seven-year struggle between FDA and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 9
Lane Labs To Pay Consumer Restitution Under Permanent Injunction
The seven-year struggle between FDA and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 9
Lane Labs To Pay Consumer Restitution Under Permanent Injunction
The seven-year struggle between FDA and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 9